Notably, while depleting Tregs can modify the tumor microenvironment, it may paradoxically accelerate tumor progression instead of enhancing CD8+ T-cell effectiveness [37], suggesting a complex interplay between different subsets of T-cells in the TME. The gene discussed is CD8A; the disease is neoplasm.